CardioCell

Breakthrough Cardiovascular Technology

CardioCell is currently exploring clinical studies for:

  • Acute Myocardial Infarction (AMI)
  • Chronic Heart Failure (CHF)
  • Heart Failure in Patients with left ventricular assist devices (LVADs)
  • Peripheral Artery Disease (PAD) — future indications